Hailstorms Damage and Your Insurance Claim
But, did you know if your insurance companies are going to compensate for every damage caused by hail or windstorm?
Weight-loss drug developers line up to tap market worth $150 billion
Novo Nordisk’s Wegovy and Eli Lilly’s Zepbound are currently the leading weight loss pharmaceutical market, and they are expected to be worth around $150 billion by the beginning of the 2030s.
J&J must pay $260 million in latest talc lawsuit trial, Oregon jury says
In a Talc Lawsuit trial, Johnson & Johnson must pay $260 million to an Oregon woman who claimed she was diagnosed with mesothelioma, which is a fatal cancer that can be linked to asbestos exposure, after inhaling the talc powder of the company, the jury found on Monday.
US judicial panel approves rule governing federal mass torts
On Tuesday, a U.S. judicial panel approved the very first rule that governs federal mass tort cases. The rule will give judges a first plan that they can follow when asked to hear hundreds or even thousands of lawsuits against corporations.
J&J acquires experimental skin disorder drug for $1.25 billion
On Tuesday, J&J finalized a deal to obtain the rights to an innovative treatment for skin conditions from Numab Therapeutics, a privately held company, in a transaction valued at approximately $1.25 billion, marking its second significant agreement this month focused on addressing eczema.
Mass torts against 3M, J&J fueled spike in new federal lawsuits in 2023
Federal judiciary reports that federal lawsuits grew by 24% during the fiscal year 2023 as people claiming to have been injured by products such as 3M’s Combat earplugs or Johnson & Johnson talcum powder grew.
Judge rejects key expert in paraquat lawsuits, tosses first cases set for trial
Paraquat lawsuits, An expert witness who is vital to cases claiming that Syngenta’s herbicide, paraquat, causes Parkinson’s disease is not able to be called in to testify in the courtroom the way a federal judge decided Wednesday, dissolving the first four lawsuits involving the product, which were scheduled to be tried.
Ozempic lead counsel selection process is model for judges in big cases
In March, during hearings that were the first hearing, which opened another tab in the ongoing litigation involving the alleged unreported side effects of Ozempic along with other diet medications, attorneys for plaintiffs told the Philadelphia federal court judge they had already decided on a team of four attorneys to head the mass tort lawsuit.
The Pros and Cons of Social Media on Mental Health
Social media is a part of everyday life, and this trend will not change anytime soon. 72% of Americans use at least one form of social media, and this trend is expected to continue as social media grows in popularity.
Roundup Lawsuits Against Bayer Will Continue After US Appeals Court Rejects Federal Preemption Argument
Roundup lawsuits will go on after the U.S. Appeals Court dismissed Bayer’s argument that they shouldn’t be shielded from state lawsuits due to federal law.
